FindTrial
Sign In

Lung function in post covid

Assessment of Respiratory Morbidities and Lung Function in COVID 19 survivors: An Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033518
Enrollment
60
Registered
2021-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: NIL: NIL

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants 18 years of age or older who had a confirmed positive COVID 19 infection.

Exclusion criteria

Exclusion criteria: 1. Refusal to give consent for the study. 2. Participants age less than 18 years. 3. Participants with pre-existing lung diseases like asthma, chronic obstructive pulmonary disease, interstitial lung disease etc. 4. Participants with contraindications for lung function studies.

Design outcomes

Primary

MeasureTime frame
To assess the prevalence and severity of respiratory morbidities in COVID 19 survivors.Timepoint: at baseline and 3 months of follow up—

Secondary

MeasureTime frame
1. To evaluate the exercise capacity by 6 minute walk test. 2. To assess the type and severity of spirometric abnormalities. 3. To estimate the lung volumes and diffusion capacity. 4. To assess the small airways function.Timepoint: at baseline and 3 months of follow up—

Countries

India

Contacts

Public ContactRahul Khera

All India Institute of Medical Sciences Raipur

sajalde@yahoo.com9406573825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026